The University of Chicago is a private research university in Chicago, Illinois. Founded in 1890, its main campus is located in Chicago's Hyde Park neighborhood. The University of Chicago is consistently ranked among the best universities in the world and it is among the most selective in the United States.

During the past decade, University of Chicago conducted 623 clinical trials. In the 10-year time frame, 623 clinical trials started and 387 clinical trials were completed, i.e. on average, 62.1% percent of trials that started reached the finish line to date. In the past 5 years, 263 clinical trials started and 193 clinical trials were completed. i.e. 73.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Chicago" #1 sponsor was "University of Chicago" with 361 trials, followed by "Bristol-Myers Squibb" with 35 trials sponsored, "National Cancer Institute (NCI)" with 35 trials sponsored, "Gilead Sciences" with 26 trials sponsored and "Celgene" with 26 trials sponsored. Other sponsors include 838 different institutions and companies that sponsored additional 437 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Chicago" #1 collaborator was "University of Chicago" with 52 trials as a collaborator, "National Cancer Institute (NCI)" with 41 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 38 trials as a collaborator, "National Institutes of Health (NIH)" with 18 trials as a collaborator and "Merck Sharp & Dohme LLC" with 16 trials as a collaborator. Other collaborators include 926 different institutions and companies that were collaborators in the rest 489 trials.

According to Clinical.Site data, the most researched conditions in "University of Chicago" are "Breast Cancer" (33 trials), "Prostate Cancer" (32 trials), "Multiple Myeloma" (27 trials), "Acute Myeloid Leukemia" (18 trials) and "Heart Failure" (17 trials). Many other conditions were trialed in "University of Chicago" in a lesser frequency.

Most popular intervention types in "University of Chicago" are "Drug" (816 trials), "Other" (163 trials), "Device" (142 trials), "Biological" (134 trials) and "Behavioral" (80 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (146 trials), "laboratory biomarker analysis" (30 trials), "Pembrolizumab" (29 trials), "placebo" (24 trials) and "Carboplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "University of Chicago" are 1151 trials for "All" genders, 95 trials for "Female" genders and 70 trials for "Male" genders.

Currently, there are 361 active trials in "University of Chicago". 12 are not yet recruiting, 219 are recruiting, 123 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 704 completed trials in University of Chicago, 5 suspended trials, and 157 terminated clinical trials to date.

Out of the total trials that were conducted in University of Chicago, 239 "Phase 1" clinical trials were conducted, 501 "Phase 2" clinical trials and 221 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 59 trials, and there were also 221 trials that are defined as “Not Applicable".

University of Chicago has several departments that took part in Clinical trials: "University Of Chicago Medical Center; Section Of Hematology/Oncology" - 30 trials, "Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease" - 22 trials, "University of Chicago, Anesthesia & Critical Care" - 17 trials, "University of Chicago; Neurology" - 7 trials, "University of Chicago Department of Medicine" - 5 trials, "University of Chicago Department of Psychiatry & Behavioral Neuroscience" - 5 trials, "University of Chicago Medicine and Biological Sciences" - 4 trials, "The University of Chicago;Department of Pediatrics" - 3 trials, "University of Chicago Medical Center; Medicine, Section of Pulmonary" - 2 trials, "University of Chicago, Department of Medicine: Rheumatology" - 2 trials, "University of Chicago Department of Medicine, Section of Endocrinology, Diabetes & Metabolism" - 2 trials